Bioequivalence Comparison of Seventeen Commercial Oral Enrofloxacins against the Original Pioneer Preparation in Broilers

Considering the importance of fluoroquinolones in animal health and the fact that the enrofloxacin patent has expired, a bioequivalence study of seventeen preparations of enrofloxacin vs. the reference preparation (Baytril®) in broilers was carried out. Oral pharmacokinetics of seventeen co...

Full description

Bibliographic Details
Main Authors: Hector Sumano, Lilia Gutierrez, Luis Ocampo
Format: Article
Language:English
Published: Japan Poultry Science Association 2006-02-01
Series:The Journal of Poultry Science
Subjects:
Online Access:https://www.jstage.jst.go.jp/article/jpsa/43/1/43_1_23/_pdf/-char/en
_version_ 1797816246133063680
author Hector Sumano
Lilia Gutierrez
Luis Ocampo
author_facet Hector Sumano
Lilia Gutierrez
Luis Ocampo
author_sort Hector Sumano
collection DOAJ
description Considering the importance of fluoroquinolones in animal health and the fact that the enrofloxacin patent has expired, a bioequivalence study of seventeen preparations of enrofloxacin vs. the reference preparation (Baytril®) in broilers was carried out. Oral pharmacokinetics of seventeen commercial enrofloxacin preparations and Baytril as reference preparation were assessed in five trials in a total of 1760 broilers. Ten mg/kg of each preparation was administered to a total of 80 clinically healthy 3 weeks old broilers. After drug administration, blood was collected 8 times from ten birds within 24h. Using a microbiological agar diffusion analysis, serum concentration of enrofloxacin and metabolites were determined by correlating the composite antibacterial activity of enrofloxacin and metabolites with actual concentration. Bioequivalence limits were set between 80 to 125% reference values for maximum serum concentration (Csmax) and area under the curve (AUC). Results display mean Baytril® values of Csmax=1.662μg/ml±0.034 ; AUC=4.073±0.814μg/ml/hr. Only three preparations out of seventeen could be regarded as bioequivalent while the rest gave AUC and/or Csmax values smaller than the accepted lower limit of the mean values obtained for the reference enrofloxacin (P<0.05). The use of non-bioequivalent preparations of enrofloxacin will consequently undermine clinical outcomes and could play a significant role in accelerating the emergence of bacterial resistance in the poultry industry.
first_indexed 2024-03-13T08:35:56Z
format Article
id doaj.art-4f9b7b8b7106455d96949f22c18f3339
institution Directory Open Access Journal
issn 1346-7395
1349-0486
language English
last_indexed 2024-03-13T08:35:56Z
publishDate 2006-02-01
publisher Japan Poultry Science Association
record_format Article
series The Journal of Poultry Science
spelling doaj.art-4f9b7b8b7106455d96949f22c18f33392023-05-31T00:17:56ZengJapan Poultry Science AssociationThe Journal of Poultry Science1346-73951349-04862006-02-01431232810.2141/jpsa.43.23jpsaBioequivalence Comparison of Seventeen Commercial Oral Enrofloxacins against the Original Pioneer Preparation in BroilersHector Sumano0Lilia Gutierrez1Luis Ocampo2Department of Physiology and Pharmacology, School of Veterina Medicine, National Autonomous University of MexicoDepartment of Physiology and Pharmacology, School of Veterina Medicine, National Autonomous University of MexicoDepartment of Physiology and Pharmacology, School of Veterina Medicine, National Autonomous University of MexicoConsidering the importance of fluoroquinolones in animal health and the fact that the enrofloxacin patent has expired, a bioequivalence study of seventeen preparations of enrofloxacin vs. the reference preparation (Baytril®) in broilers was carried out. Oral pharmacokinetics of seventeen commercial enrofloxacin preparations and Baytril as reference preparation were assessed in five trials in a total of 1760 broilers. Ten mg/kg of each preparation was administered to a total of 80 clinically healthy 3 weeks old broilers. After drug administration, blood was collected 8 times from ten birds within 24h. Using a microbiological agar diffusion analysis, serum concentration of enrofloxacin and metabolites were determined by correlating the composite antibacterial activity of enrofloxacin and metabolites with actual concentration. Bioequivalence limits were set between 80 to 125% reference values for maximum serum concentration (Csmax) and area under the curve (AUC). Results display mean Baytril® values of Csmax=1.662μg/ml±0.034 ; AUC=4.073±0.814μg/ml/hr. Only three preparations out of seventeen could be regarded as bioequivalent while the rest gave AUC and/or Csmax values smaller than the accepted lower limit of the mean values obtained for the reference enrofloxacin (P<0.05). The use of non-bioequivalent preparations of enrofloxacin will consequently undermine clinical outcomes and could play a significant role in accelerating the emergence of bacterial resistance in the poultry industry.https://www.jstage.jst.go.jp/article/jpsa/43/1/43_1_23/_pdf/-char/enbioequivalencebroilersenrofloxacin
spellingShingle Hector Sumano
Lilia Gutierrez
Luis Ocampo
Bioequivalence Comparison of Seventeen Commercial Oral Enrofloxacins against the Original Pioneer Preparation in Broilers
The Journal of Poultry Science
bioequivalence
broilers
enrofloxacin
title Bioequivalence Comparison of Seventeen Commercial Oral Enrofloxacins against the Original Pioneer Preparation in Broilers
title_full Bioequivalence Comparison of Seventeen Commercial Oral Enrofloxacins against the Original Pioneer Preparation in Broilers
title_fullStr Bioequivalence Comparison of Seventeen Commercial Oral Enrofloxacins against the Original Pioneer Preparation in Broilers
title_full_unstemmed Bioequivalence Comparison of Seventeen Commercial Oral Enrofloxacins against the Original Pioneer Preparation in Broilers
title_short Bioequivalence Comparison of Seventeen Commercial Oral Enrofloxacins against the Original Pioneer Preparation in Broilers
title_sort bioequivalence comparison of seventeen commercial oral enrofloxacins against the original pioneer preparation in broilers
topic bioequivalence
broilers
enrofloxacin
url https://www.jstage.jst.go.jp/article/jpsa/43/1/43_1_23/_pdf/-char/en
work_keys_str_mv AT hectorsumano bioequivalencecomparisonofseventeencommercialoralenrofloxacinsagainsttheoriginalpioneerpreparationinbroilers
AT liliagutierrez bioequivalencecomparisonofseventeencommercialoralenrofloxacinsagainsttheoriginalpioneerpreparationinbroilers
AT luisocampo bioequivalencecomparisonofseventeencommercialoralenrofloxacinsagainsttheoriginalpioneerpreparationinbroilers